The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

8 articles for Y Nakai


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and evaluation of¿-lactam analogs of PGE2 as EP4 and EP2/EP4 agonists.EBI
Minase Research Institute
Discovery of new chemical leads for prostaglandin D2 receptor antagonists.EBI
Minase Research Institute
Study on selectin blocker. 8. Lead discovery of a non-sugar antagonist using a 3D-pharmacophore model.EBI
Nippon Organon K.K.
Discovery of novel prostaglandin analogs as potent and selective EP2/EP4 dual agonists.EBI
Minase Research Institute
Discovery of a novel EP2/EP4 dual agonist with high subtype-selectivity.EBI
Minase Research Institute
Discovery of novel N-acylsulfonamide analogs as potent and selective EP3 receptor antagonists.EBI
Minase Research Institute
3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. part 2: optimization of the side chains to improve in vitro and in vivo potencies.EBI
Minase Research Institute
Discovery of orally active prostaglandin D2 receptor antagonists.EBI
Minase Research Institute